In a significant stride towards combating metastatic breast cancer, Israeli researchers unveiled a novel therapeutic approach utilizing already-existing medications that offers hope for improved survival rates.
Bengaluru (Karnataka) [India], February 15: Every year, over 400,000 children and adolescents worldwide are diagnosed with cancer. While the survival rate in High-Income Countries stands at 80 per cent, it drops drastically to as low as 20 per cent in Low and Middle-Income Countries. On Inte
Pune (Maharashtra) [India], December 29: Respiratory illnesses constitute a significant threat to health, affecting individuals across all age groups and standing as common causes of morbidity and mortality. The intricate nature of these disorders necessitates specialised training for health
With an overall survival rate of more than 85% five years after diagnosis, the number of children cancer survivors in the United States is rising. However, survivors may still be more susceptible to a number of illnesses, such as second cancers.
The number of childhood cancer survivors in the United States is growing, with an overall survival rate of more than 85 per cent five years following diagnosis. Survivors, however, may still be at higher risk of a variety of health issues, including second malignancies.
People with multiple myeloma, a blood malignancy of plasma cells in the bone marrow, have a poorer overall survival rate when compared to individuals without diabetes. This difference in survival due to diabetes was found in white patients in a subgroup analysis but not in black patients, ac
When compared to people without diabetes, those with multiple myeloma, a blood malignancy of plasma cells in the bone marrow, have a worse overall survival rate. According to a study published today in Blood Advances, this difference in survival related to diabetes was detected in white pati
The five-year survival rate for all children with acute lymphatic leukaemia (ALL) has risen to 94 per cent. A study of 800 Dutch youngsters demonstrates this. Modified treatment procedures for four subgroups were investigated in the research. The changes were discovered to have a favourable
The cancer immunotherapy atezolizumab1 significantly increased the overall survival of patients with advanced stage non-small cell lung cancer who were unable to receive platinum-containing chemotherapy when compared to single-agent chemotherapy, according to a global study conducted by UCL
According to research, the survival rate in children with drug-resistant epilepsy (DRE) was highest following cranial epilepsy surgery and lowest when treated simply with antiseizure medicines.
The survival rate for people with advanced bladder cancer is less than a year, making it the fourth most common cancer diagnosed in men. The bladder cancer patients who will benefit from immunotherapy are unknown to doctors.
According to the reports of the largest study, active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery.